Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2011 2
2012 3
2013 7
2014 6
2015 8
2016 8
2017 3
2018 4
2019 2
2020 1
2021 6
2022 7
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma.
Schoot RA, van Ewijk R, von Witzleben AA, Kao SC, Merks JHMH, Morosi C, Pace E, Shulkin BL, Ferrari A, von Kalle T, van Rijn RR, Weiss AR, Sparber-Sauer M, Ter Horst SAJ, McCarville MB. Schoot RA, et al. Among authors: van ewijk r. Eur J Radiol. 2023 Sep;166:111012. doi: 10.1016/j.ejrad.2023.111012. Epub 2023 Jul 25. Eur J Radiol. 2023. PMID: 37541182 Review.
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
van Ewijk R, Cleirec M, Herold N, le Deley MC, van Eijkelenburg N, Boudou-Rouquette P, Risbourg S, Strauss SJ, Palmerini E, Boye K, Kager L, Hecker-Nolting S, Marchais A, Gaspar N; FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials. van Ewijk R, et al. Cancer Treat Rev. 2023 Nov;120:102625. doi: 10.1016/j.ctrv.2023.102625. Epub 2023 Sep 15. Cancer Treat Rev. 2023. PMID: 37738712 Free article. Review.
Imaging in rhabdomyosarcoma: a patient journey.
de Vries ISA, van Ewijk R, Adriaansen LME, Bohte AE, Braat AJAT, Fajardo RD, Hiemcke-Jiwa LS, Hol MLF, Ter Horst SAJ, de Keizer B, Knops RRG, Meister MT, Schoot RA, Smeele LE, van Scheltinga ST, Vaarwerk B, Merks JHM, van Rijn RR. de Vries ISA, et al. Among authors: van ewijk r. Pediatr Radiol. 2023 Apr;53(4):788-812. doi: 10.1007/s00247-023-05596-8. Epub 2023 Feb 27. Pediatr Radiol. 2023. PMID: 36843091 Free PMC article.
[Juvenile spring eruption].
van Ewijk R, Marees CH. van Ewijk R, et al. Ned Tijdschr Geneeskd. 2011;155:A2417. Ned Tijdschr Geneeskd. 2011. PMID: 21447213 Dutch.
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma.
Haveman LM, van Ewijk R, van Dalen EC, Breunis WB, Kremer LC, van den Berg H, Dirksen U, Merks JH. Haveman LM, et al. Among authors: van ewijk r. Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD011406. doi: 10.1002/14651858.CD011406.pub2. Cochrane Database Syst Rev. 2021. PMID: 34472084 Free PMC article. Review.
Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A, Shipley J, van Rijn RR, de Vries I, van Ewijk R, de Keizer B, Gatz SA, Casanova M, Hjalgrim LL, Firth C, Wheatley K, Kearns P, Liu W, Kirkham A, Rees H, Bisogno G, Wasti A, Wakeling S, Heenen D, Tweddle DA, Merks JHM, Jenney M. Chisholm J, et al. Among authors: van ewijk r. Cancers (Basel). 2024 Feb 29;16(5):998. doi: 10.3390/cancers16050998. Cancers (Basel). 2024. PMID: 38473359 Free PMC article.
59 results